These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 9623204

  • 1. [Differences between diabetes mellitus type 2 patients switched and not switched over to insulin treatment after specialist consultation].
    Goddijn PP, Meyboom-de Jong B, Feskens EJ, van Ballegooie E, Bilo HJ.
    Ned Tijdschr Geneeskd; 1998 May 02; 142(18):1023-6. PubMed ID: 9623204
    [Abstract] [Full Text] [Related]

  • 2. [Initiating insulin therapy in patients with diabetes mellitus type 2: in a transmural setting is at least as effective as in an outpatient setting; a retrospective study with a 4-year follow-up].
    Rosendal H, Vondeling H, de Witte LP, Hutubessy RC, van Beekum WT, Heine RJ.
    Ned Tijdschr Geneeskd; 2002 Jan 26; 146(4):166-71. PubMed ID: 11845567
    [Abstract] [Full Text] [Related]

  • 3. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA, Stolk RP, Heerdink ER, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE.
    Pharmacoepidemiol Drug Saf; 2003 Mar 26; 12(2):121-7. PubMed ID: 12642975
    [Abstract] [Full Text] [Related]

  • 4. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D.
    Clin Ther; 2000 Jun 26; 22(6):709-18. PubMed ID: 10929918
    [Abstract] [Full Text] [Related]

  • 5. Factors associated with switching from oral hypoglycaemic agents to insulin therapy.
    Spoelstra JA, Stol RP, de Bruyne MC, Erkens JA, Herings RM, Leufkens HG, Grobbee DE.
    Neth J Med; 2002 Jul 26; 60(6):243-8. PubMed ID: 12365467
    [Abstract] [Full Text] [Related]

  • 6. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R.
    Patient Educ Couns; 2008 Oct 26; 73(1):50-9. PubMed ID: 18583087
    [Abstract] [Full Text] [Related]

  • 7. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J, Kooy A, Lehert P, Bets D, Wulffelé MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD.
    J Intern Med; 2005 Jan 26; 257(1):100-9. PubMed ID: 15606381
    [Abstract] [Full Text] [Related]

  • 8. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, IMPROVE Study Group Expert Panel.
    Int J Clin Pract; 2009 Mar 26; 63(3):522-31. PubMed ID: 19187170
    [Abstract] [Full Text] [Related]

  • 9. The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss.
    Rowe R, Cowx M, Poole C, McEwan P, Morgan C, Walker M.
    Curr Med Res Opin; 2005 Nov 26; 21(11):1885-90. PubMed ID: 16307710
    [Abstract] [Full Text] [Related]

  • 10. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 26; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 11. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus.
    Kanoun F, Ben Amor Z, Zouari B, Ben Khalifa F.
    Diabetes Metab; 2001 Dec 26; 27(6):695-700. PubMed ID: 11852379
    [Abstract] [Full Text] [Related]

  • 12. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W, Majkowska L, Stefański A, Moleda P.
    Przegl Lek; 2005 Dec 26; 62(4):201-5. PubMed ID: 16229234
    [Abstract] [Full Text] [Related]

  • 13. Intensification of therapy and no increase in body mass index with longer disease duration in type 2 diabetes mellitus (ZODIAC-5).
    Logtenberg SJ, Kleefstra N, Ubink-Veltmaat LJ, Houweling ST, Bilo HJ.
    Fam Pract; 2007 Dec 26; 24(6):529-31. PubMed ID: 18039725
    [Abstract] [Full Text] [Related]

  • 14. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
    Gao Y, Guo XH, Vaz JA, PRESENT Study Group.
    Diabetes Obes Metab; 2009 Jan 26; 11(1):33-40. PubMed ID: 18494806
    [Abstract] [Full Text] [Related]

  • 15. Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.
    Zargar AH, Masoodi SR, Laway BA, Wani AI, Bashir MI.
    J Assoc Physicians India; 2002 May 26; 50(5):641-6. PubMed ID: 12186116
    [Abstract] [Full Text] [Related]

  • 16. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.
    Clin Ther; 2007 Jun 26; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
    Sieradzki J, Soszyński P.
    Przegl Lek; 1999 Jun 26; 56(5):335-41. PubMed ID: 10554569
    [Abstract] [Full Text] [Related]

  • 18. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L, Giammattei J, Acquistapace M, Bornstein K, Sommermann E, Pettitt DJ.
    Clin Ther; 2004 Sep 26; 26(9):1492-7. PubMed ID: 15531011
    [Abstract] [Full Text] [Related]

  • 19. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M.
    Ann Acad Med Stetin; 2004 Sep 26; 50(2):29-39. PubMed ID: 16529163
    [Abstract] [Full Text] [Related]

  • 20. Treating non-insulin-dependent diabetes. Oral agents or insulin?
    Shlossberg AH.
    Can Fam Physician; 1993 Jan 26; 39():119-20, 123-6. PubMed ID: 8435549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.